Dr. Kate Hillier's practice focuses on the representation of public and private life sciences companies discovering, developing and marketing biopharmaceutical, vaccine, medical device, diagnostic and digital health products.

Download full bio 


  • Cell Design Labs Sells to Gilead 

  • Cell Design Labs: Collaboration Agreement with Kite Pharma and Simultaneous Series of Private Financings 

  • 23andMe in its Multi-year Collaboration with GSK 

  • Vir Biotechnology - $143 Million IPO 

  • Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion 

  • View all


  • University of Cambridge (Jesus College)
    JD, with First Class honors, 2005

  • Oxford Institute of Legal Practice
    Diploma in Legal Practice, with distinction, 2005

  • Australian and New Zealand College of Anaesthetists
    Fellowship, 2002

  • University of Adelaide
    MBBS (Medicine and Surgery), with distinction

Admissions & Credentials



England & Wales


  • State Bar of California

  • Solicitors Regulation Authority in the United Kingdom

Rankings & Accolades

    Legal 500: Next Generation Partner, Healthcare: Life Sciences